A systematic review of depression and anxiety in patients with atrial fibrillation: The mind-heart link

Cardiovascular Psychiatry and Neurology

Volumn 2013, Issue , 2013, Pages

  Patel, Dimpi ^a   Mc Conkey, Nathaniel D ^a   Sohaney, Ryann ^a   Mc Neil, Ashley ^a   Jedrzejczyk, Andy ^a   Armaganijan, Luciana ^b  

^a ST VINCENT MERCY MEDICAL CENTER   (United States)

^b INSTITUTO DANTE PAZZANESE DE CARDIOLOGIA   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN II; ANTIARRHYTHMIC AGENT; ANTIDEPRESSANT AGENT; C REACTIVE PROTEIN; COLLAGENASE; INTERLEUKIN 6; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA;

ANXIETY; CLINICAL PRACTICE; DEPRESSION; FOLLOW UP; HEART ATRIUM FIBRILLATION; HUMAN; NAMED GROUPS BY MARITAL STATUS; PATHOPHYSIOLOGY; PERCEPTION; PREVALENCE; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; SYSTEMATIC REVIEW;

EID: 84878118313     PISSN: 20900163     EISSN: 20900171     Source Type: Journal    
DOI: 10.1155/2013/159850     Document Type: Review

References (62)

1. Coromilas J., Obesity and atrial fibrillation: is one epidemic feeding the other? Journal of the American Medical Association 2004 292 20 2519 2520 2-s2.0-9244232300 10.1001/jama.292.20.2519 (Pubitemid 39552680)
2. Naccarelli G. V., Varker H., Lin J., Schulman K. L., Increasing prevalence of atrial fibrillation and flutter in the United States. The American Journal of Cardiology 2009 104 11 1534 1539 2-s2.0-71649105333 10.1016/j.amjcard.2009.07.022
3. Benjamin E. J., Levy D., Vaziri S. M., D'Agostino R. B., Belanger A. J., Wolf P. A., Independent risk factors for atrial fibrillation in a population based cohort. The framingham heart study. Journal of the American Medical Association 1994 271 11 840 844 2-s2.0-0028299731 10.1001/jama.271.11.840 (Pubitemid 24076851)
4. Fuster V., Rydén L. E., Cannom D. S., Crijns H. J., Curtis A. B., Ellenbogen K. A., Halperin J. L., Le Heuzey J. Y., Kay G. N., Lowe J. E., Olsson S. B., Prystowsky E. N., Tamargo J. L., Wann S., Priori S. G., Blanc J. J., Budaj A., Camm A. J., Dean V., Deckers J. W., Despres C., Dickstein K., Lekakis J., McGregor K., Metra M., Morais J., Osterspey A., Zamorano J. L., Smith S. C., Jacobs A. K., Adams C. D., Anderson J. L., Antman E. M., Hunt S. A., Nishimura R., Ornato J. P., Page R. L., Riegel B., ACC/AHA/ESC 2006 Guidelines for the management of patients with atrial fibrillation: executive summary. European Heart Journal 2006 27 16 1979 2030 2-s2.0-33748156096 10.1093/eurheartj/ehl176 (Pubitemid 44313588)
5. Thrall G., Lane D., Carroll D., Lip G. Y. H., Quality of life in patients with atrial fibrillation: a systemic review. The American Journal of Medicine 2006 119 5 448.e1 448.e19 2-s2.0-33646129883 10.1016/j.amjmed.2005.10.057
6. Hajduk A., Korzonek M., Przybycien K., Ertmanski S., Stolarek J., Measurement of anxiety with C.D. Spielberger's test in patients with cardiac arrhythmias. Annales Academiae Medicae Stetinensis 2009 55 1 48 51
7. Garg R., Punj J., Gupta P., Darlong V., Pandey R., Perioperative atrial fibrillation in five patients-role of anxiety. Journal of Anaesthesiology Clinical Pharmacology 2011 27 1 135 137 2-s2.0-79951922117
8. Pozeuelo L., Fine tuning a heart-brain connection: anxiety in atrial fibrillation. Circulation 2012 5 3 307 308
9. McCabe P. J., Psychological distress in patients diagnosed with atrial fibrillation: the state of the science. Journal of Cardiovascular Nursing 2010 25 1 40 51 2-s2.0-76649085861 10.1097/JCN.0b013e3181b7be36
10. Hansson A., Madsen-Härdig B., Olsson S. B., Arrhythmia-provoking factors and symptoms at the onset of paroxysmal atrial fibrillation: a study based on interviews with 100 patients seeking hospital assistance. BMC Cardiovascular Disorders 2004 4, article 13 2-s2.0-13144300873 10.1186/1471-2261-4-13 (Pubitemid 40180354)
11. Statins becoming ever more versatile. Now also for prevention of atrial fibrillation and depression. MMW Fortschritte der Medizin 2003 145 16 10
12. Hansson A., Olsson B., Paroxysmal fibrillation as a clinical problem. More studies on the anxiety-inducing disorder are needed. Lakartidningen 1994 91 47 4372 4379 2-s2.0-0028779368
13. Dabrowski R., Smolis-Bak E., Kowalik I., Kazimierska B., Wójcicka M., Szwed H., Quality of life and depression in patients with different patterns of atrial fibrillation. Kardiologia Polska 2010 68 10 1133 1139 2-s2.0-78149302567
14. Frasure-Smith N., Lespérance F., Habra M., Talajic M., Khairy P., Dorian P., Roy D., Elevated depression symptoms predict long-term cardiovascular mortality in patients with atrial fibrillation and heart failure. Circulation 2009 120 2 134 140 2-s2.0-67651091958 10.1161/CIRCULATIONAHA.109.851675
15. Kang Y., Effect of uncertainty on depression in patients with newly diagnosed atrial fibrillation. Progress in Cardiovascular Nursing 2006 21 2 83 88 2-s2.0-33746040558 10.1111/j.0889-7204.2006.04810.x
16. Rommel J., Simpson R., Mounsey J. P., Chung E., Schwartz J., Pursell I., Gehi A., Effect of body mass index, physical activity, depression, and educational attainment on high-sensitivity C-reactive protein in patients with atrial fibrillation. The American Journal of Cardiology 2013 111 2 208 212 10.1016/j.amjcard.2012.09.017
17. Suzuki S. I., Kasanuki H., The influences of psychosocial aspects and anxiety symptoms on quality of life of patients with arrhythmia: investigation in paroxysmal atrial fibrillation. International Journal of Behavioral Medicine 2004 11 2 104 109 2-s2.0-4143067894 (Pubitemid 39093267)
18. Eaker E. D., Sullivan L. M., Kelly-Hayes M., D'Agostino R. B., Benjamin E. J., Tension and anxiety and the prediction of the 10-year incidence of coronary heart disease, atrial fibrillation, and total mortality: the framingham offspring study. Psychosomatic Medicine 2005 67 5 692 696 2-s2.0-25844509237 10.1097/01.psy.0000174050.87193.96 (Pubitemid 41396013)
19. Thrall G., Lip G. Y. H., Carroll D., Lane D., Depression, anxiety, and quality of life in patients with atrial fibrillation. Chest 2007 132 4 1259 1264 2-s2.0-35248841295 10.1378/chest.07-0036 (Pubitemid 47621002)
20. Ong L., Irvine J., Nolan R., Cribbie R., Harris L., Newman D., Mangat I., Dorian P., Gender differences and quality of life in atrial fibrillation: the mediating role of depression. Journal of Psychosomatic Research 2006 61 6 769 774 2-s2.0-33751531778 10.1016/j.jpsychores.2006.08.003 (Pubitemid 44830039)
21. Perret-Guillaume C., Briancon S., Wahl D., Guillemin F., Empereur F., Quality of Life in elderly inpatients with atrial fibrillation as compared with controlled subjects. Journal of Nutrition, Health and Aging 2010 14 2 161 166 2-s2.0-77952300816
22. Ariansen I., Dammen T., Abdelnoor M., Tveit A., Gjesdal K., Mental health and sleep in permanent atrial fibrillation patients from the general population. Clinical Cardiology 2011 34 5 327 331 2-s2.0-79955895921 10.1002/clc.20883
23. Trovato G. M., Pace P., Cangemi E., Martines G. F., Trovato F. M., Catalano D., Gender, lifestyles, illness perception and stress in stable atrial fibrillation. Clinica Terapeutica 2012 163 4 281 286
24. McCabe P. J., Barnason S. A., Houfek J., Illness beliefs in patients with recurrent symptomatic atrial fibrillation. Pacing and Clinical Electrophysiology 2011 34 7 810 820 2-s2.0-79959952321 10.1097/JCN. 0b013e31821e7ab1
25. Ong L., Cribbie R., Harris L., Dorian P., Newman D., Mangat I., Nolan R., Irvine J., Psychological correlates of quality of life in atrial fibrillation. Quality of Life Research 2006 15 8 1323 1333 2-s2.0-33750559143 10.1007/s11136-006-0029-5 (Pubitemid 44673608)
26. Whang W., Davidson K. W., Conen D., Tedrow U. B., Everett B. M., Albert C. M., Global psychological distress and risk of atrial fibrillation among women: the women's health study. Journal of the American Heart Association 2012 1 3 e001107 10.1161/JAHA.112.001107
27. Lane D. A., Langman C. M., Lip G. Y. H., Nouwen A., Illness perceptions, affective response, and health-related quality of life in patients with atrial fibrillation. Journal of Psychosomatic Research 2009 66 3 203 210 2-s2.0-59849117163 10.1016/j.jpsychores.2008.10.007
28. Gehi A. K., Sears S., Goli N., Walker T. J., Chung E., Schwartz J., Wood K. A., Guise K., Mounsey J. P., Psychopathology and symptoms of atrial fibrillation: implications for therapy. Journal of Cardiovascular Electrophysiology 2012 23 5 473 478 10.1111/j.1540-8167.2011.02264.x
29. Son Y. J., Song E. K., The impact of type D personality and high-sensitivity C-reactive protein on health-related quality of life in patients with atrial fibrillation. European Journal of Cardiovascular Nursing 2012 11 3 304 312
30. Tully P. J., Bennetts J. S., Baker R. A., McGavigan A. D., Turnbull D. A., Winefield H. R., Anxiety, depression, and stress as risk factors for atrial fibrillation after cardiac surgery. Heart and Lung 2011 40 1 4 11 2-s2.0-79951512059 10.1016/j.hrtlng.2009.12.010
31. Frasure-Smith N., Lespérance F., Talajic M., Khairy P., Dorian P., Meara E O., Roy D., Anxiety sensitivity moderates prognostic importance of rhythm-control versus rate-control strategies in patients with atrial fibrillation and congestive heart failure: insights from the atrial fibrillation and congestive heart failure trial. Circulation 2012 5 3 322 330 10.1161/CIRCHEARTFAILURE.111.964122
32. Lange H. W., Herrmann-Lingen C., Depressive symptoms predict recurrence of atrial fibrillation after cardioversion. Journal of Psychosomatic Research 2007 63 5 509 513 2-s2.0-35549000175 10.1016/j.jpsychores.2007.07.010 (Pubitemid 350007666)
33. Fichtner S., Deisenhofer I., Kindsmüller S., Dzijan-Horn M., Tzeis S., Reents T., Wu J., Luise E. H., Jilek C., Ammar S., Kathan S., Hessling G., Ladwig K. H., Prospective assessment of short- and long-term quality of life after ablation for atrial fibrillation. Journal of Cardio Electrophysiol 2012 3 2 121 127
34. Wokhlu A., Monahan K. H., Hodge D. O., Asirvatham S. J., Friedman P. A., Munger T. M., Bradley D. J., Bluhm C. M., Haroldson J. M., Packer D. L., Long-term quality of life after ablation of atrial fibrillation the impact of recurrence, symptom relief, and placebo effect. Journal of the American College of Cardiology 2010 55 21 2308 2316 2-s2.0-77952163349 10.1016/j.jacc.2010.01.040
35. Sang C. H., Chen K., Pang X. F., Dong J. Z., Du X., Ma H., Liu J. H., Ma C. S., Sun Y. X., Depression, anxiety, and quality of life after catheter ablation in patients with paroxysmal atrial fibrillation. Clinical Cardiology 2012 36 1 40 45
36. Mohanty S., Mohanty P., Di Biase L., Bai R., Dixon A., Burkhardt D., Gallinghouse J. G., Horton R., Sanchez J. E., Bailey S., Zagrodzky J., Natale A., Influence of body mass index on quality of life in atrial fibrillation patients undergoing catheter ablation. Heart Rhythm 2011 8 12 1847 1852 10.1016/j.hrthm.2011.07.005
37. Yu S. B., Hu W., Zhao Q. Y., Qin M., Huang H., Cui H. Y., Huang C. X., Effect of anxiety and depression on the recurrence of persistent atrial fibrillation after circumferential pulmonary vein ablation. Chinese Medical Journal 2012 125 24 4368 4372
38. Lakkireddy D., Atkins D., Pillarisetti J., Ryschon K., Bommana S., Drisko J., Vanga S., Dawn B., Effect of yoga on arrhythmia burden, anxiety, depression, and quality of life in paroxysmal atrial fibrillation: the YOGA my heart study. Journal of the American College of Cardiology 2013 61 11 1177 1182 10.1016/j.jacc.2012.11.060
39. Rudisch B., Nemeroff C. B., Epidemiology of comorbid coronary artery disease and depression. Biological Psychiatry 2003 54 3 227 240 2-s2.0-0141609605 10.1016/S0006-3223(03)00587-0 (Pubitemid 37267853)
40. Koenig H. G., Depression in hospitalized older patients with congestive heart failure. General Hospital Psychiatry 1998 20 1 29 43 2-s2.0-0031887805 10.1016/S0163-8343(98)80001-7 (Pubitemid 28109986)
41. Barth J., Schumacher M., Herrmann-Lingen C., Depression as a risk factor for mortality in patients with coronary heart disease: a meta-analysis. Psychosomatic Medicine 2004 66 6 802 813 2-s2.0-9244240975 10.1097/01.psy. 0000146332.53619.b2 (Pubitemid 39552862)
42. Aviles R. J., Martin D. O., Apperson-Hansen C., Houghtaling P. L., Rautaharju P., Kronmal R. A., Tracy R. P., Van Wagoner D. R., Psaty B. M., Lauer M. S., Chung M. K., Inflammation as a risk factor for atrial fibrillation. Circulation 2003 108 24 3006 3010 2-s2.0-0346995016 10.1161/01.CIR.0000103131. 70301.4F (Pubitemid 37553570)
43. Pasic J., Levy W. C., Sullivan M. D., Cytokines in depression and heart failure. Psychosomatic Medicine 2003 65 2 181 193 2-s2.0-0037344950 10.1097/01.PSY.0000058372.50240.38 (Pubitemid 36359329)
44. Chung M. K., Martin D. O., Sprecher D., Wazni O., Kanderian A., Carnes C. A., Bauer J. A., Tchou P. J., Niebauer M. J., Natale A., Van Wagoner D. R., C-reactive protein elevation in patients with atrial arrhythmias: Inflammatory mechanisms and persistence of atrial fibrillation. Circulation 2001 104 24 2886 2891 2-s2.0-0035846667 (Pubitemid 33139098)
45. Dernellis J., Panaretou M., C-reactive protein and paroxysmal atrial fibrillation: evidence of the implication of an inflammatory process in paroxysmal atrial fibrillation. Acta Cardiologica 2001 56 6 375 380 2-s2.0-0035746392
46. Malouf J. F., Kanagala R., Al Atawi F. O., Rosales A. G., Davison D. E., Murali N. S., Tsang T. S. M., Chandrasekaran K., Ammash N. M., Friedman P. A., Somers V. K., High sensitivity C-reactive protein: a novel predictor for recurrence of atrial fibrillation after successful cardioversion. Journal of the American College of Cardiology 2005 46 7 1284 1287 2-s2.0-27744481291 10.1016/j.jacc.2005.06.053 (Pubitemid 41615550)
47. Carney R. M., Freedland K. E., Veith R. C., Depression, the autonomic nervous system, and coronary heart disease. Psychosomatic Medicine 2005 67 supplement 1 S29 S33 2-s2.0-14044261039 10.1097/01.psy.0000162254.61556.d5 (Pubitemid 40721029)
48. Murck H., Held K., Ziegenbein M., Künzel H., Koch K., Steiger A., The renin-angiotensin-aldosterone system in patients with depression compared to controls-a sleep endocrine study. BMC Psychiatry 2003 3, article 15 2-s2.0-2642513171 10.1186/1471-244X-3-15 (Pubitemid 38729340)
49. Takahashi N., Kume O., Wakisaka O., Fukunaga N., Teshima Y., Hara M., Saikawa T., Novel strategy to prevent atrial fibrosis and fibrillation. Circulation Journal 2012 76 10 2318 2326 10.1253/circj.CJ-12-1099
50. Hagens V. E., Vermeulen K. M., Tenvergert E. M., Van Veldhuisen D. J., Bosker H. A., Kamp O., Kingma J. H., Tijssen J. G. P., Crijns H. J. G. M., Van Gelder I. C., Rate control is more cost-effective than rhythm control for patients with persistent atrial fibrillation-results from the rate Control versus electrical cardioversion (RACE) study. European Heart Journal 2004 25 17 1542 1549 2-s2.0-4444312744 10.1016/j.ehj.2004.06.020 (Pubitemid 39165633)
51. Grönefeld G. C., Lilienthal J., Kuck K. H., Hohnloser S. H., Impact of rate versus rhythm control on quality of life in patients with persistent atrial fibrillation: results from a prospective randomized study. European Heart Journal 2003 24 15 1430 1436 2-s2.0-17944392116 10.1016/S0195-668X(03)00261-6 (Pubitemid 36961833)
52. Berry C., Electrical cardioversion for atrial fibrillation: outcomes in "real life" clinical practice. International Journal of Cardiology 2001 81 1 29 35 10.1016/S0167-5273(01)00522-8 (Pubitemid 33022658)
53. Shirayama T., Sakamoto T., Sakatani T., Mani H., Yamamoto T., Matsubara H., Usefulness of paroxetine in depressed men with paroxysmal atrial fibrillation. The American Journal of Cardiology 2006 97 12 1749 1751 2-s2.0-33744549186 10.1016/j.amjcard.2006.01.038 (Pubitemid 43817866)
54. Buff D. D., Brenner R., Kirtane S. S., Gilboa R., Dysrhythmia associated with fluoxetine treatment in an elderly patient with cardiac disease. Journal of Clinical Psychiatry 1991 52 4 174 176 2-s2.0-0025728637
55. Spier S. A., Frontera M. A., Unexpected deaths in depressed medical inpatients treated with fluoxetine. Journal of Clinical Psychiatry 1991 52 9 377 382 2-s2.0-0025948494
56. Fayssoil A., Issi J., Guerbaa M., Raynaud J. C., Heroguelle V., Torsade de pointes induced by citalopram and amiodarone. Annales de Cardiologie et d'Angeiologie 2011 60 3 165 168 2-s2.0-79959266266 10.1016/j.ancard.2010.12.002
57. Castro V. M., Clements C. C., Murphy S. N., Gainer V. S., Fava M., Weilburg J. B., Erb J. L., Churchill S. E., Kohane I. S., Iosifescu D. V., Smoller J. W., Perlis R. H., QT interval and antidepressant use: a cross sectional study of electronic health records. BMJ 2013 29 f288 10.1136/bmj.f288
58. Roden D. M., Drug-Induced Prolongation of the QT Interval. The New England Journal of Medicine 2004 350 10 1013 1022 2-s2.0-1442306232 10.1056/NEJMra032426 (Pubitemid 38269278)
59. Cochran K. A., Cavalarri L. H., Shapiro N. L., Bishop J. R., Bleeding incidence with concomitant use of antidepressants and warfarin. Therapeutic Drug Monitoring 2011 33 4 433 438 10.1097/FTD.0b013e318224996e
60. Dalton S. O., Johansen C., Mellemkjaer L., Use of selective serotonin reuptake inhibitors and risk of upper gastrointestinal tract bleeding a population-based cohort study. Archives of Internal Medicine 2003 163 1 59 64 2-s2.0-13744265417 10.1001/archinte.163.1.59 (Pubitemid 36091601)
61. Meijer W. E. E., Heerdink E. R., Nolen W. A., Herings R. M. C., Leufkens H. G. M., Egberts A. C. G., Association of risk of abnormal bleeding with degree of serotonin reuptake inhibition by antidepressants. Archives of Internal Medicine 2004 164 21 2367 2370 2-s2.0-8844233380 10.1001/archinte.164.21.2367 (Pubitemid 39532249)
62. Pradaxa Official FDA information, side effects and uses. Drugs.com. Retrieved, 2013